2m 2m 2m 2m 2m 2m 2m
ZENTALIS PHARMA (ZNTL)
NASDAQ
$3.81+$0.09 (+2.39%)
Price as of Jun 03, 2026 7:53 PM EDT- $284.7MMarket Cap
- 190.44%1-Year Change
- BiotechnologyIndustry
ZENTALIS PHARMA (ZNTL)
$3.81+$0.09 (+2.39%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 67.4M N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 -100.00% | 67.4M N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -107.3M -36.05% | -167.8M -11.51% | -189.6M +9.76% | -172.7M -1.63% | |
Depreciation and Amortization Expense | 739,000 -42.67% | 1.3M -7.20% | 1.4M -2.59% | 1.4M +162.13% | |
Total Operating Expenses | 152.8M -40.91% | 258.6M -13.65% | 299.5M +31.78% | 227.3M +4.96% | |
Operating Profit | -152.8M -20.08% | -191.2M -36.16% | -299.5M +31.78% | -227.3M +4.96% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Income before Taxes | -136.6M -17.55% | -165.7M -40.16% | -276.9M +25.12% | -221.3M +34.48% | |
Income Taxes | 442,000 +149.72% | 177,000 +129.45% | -601,000 +28.14% | -469,000 +57.91% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -137.1M -17.35% | -165.8M -43.24% | -292.2M +23.39% | -236.8M +49.19% | |
Net Income from Continuing Operations Applicable to Common | -137.1M -17.35% | -165.8M -43.24% | -292.2M +23.39% | -236.8M +43.90% | |
Basic EPS and Net Income | -1.91 -18.03% | -2.33 -47.87% | -4.47 -0.22% | -4.48 +20.43% | |
Diluted EPS and Net Income | -1.91 -18.03% | -2.33 -47.87% | -4.47 -0.22% | -4.48 N/A | |
Basic Weighted Average Shares | 71.9M +1.11% | 71.1M +8.67% | 65.4M +23.75% | 52.9M +23.82% | |
Diluted Weighted Average Shares | 71.9M +1.11% | 71.1M +8.67% | 65.4M +23.75% | 52.9M +23.82% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 36.0M +6.18% | 33.9M +20.91% | 28.0M -34.90% | 43.1M -27.87% | |
Short-Term Investments | 209.9M -34.00% | 318.0M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 245.9M -30.13% | 351.9M +1,155.12% | 28.0M -34.90% | 43.1M -27.87% | |
Total Current Assets | 253.2M -34.42% | 386.1M -22.28% | 496.7M +9.91% | 451.9M +28.84% | |
Accumulated Depreciation | 2.8M -35.10% | 4.3M +35.77% | 3.1M +52.82% | 2.1M +160.10% | |
Property and Plant and Equipment and Net | 2.8M -41.05% | 4.7M -19.25% | 5.8M -24.48% | 7.7M -5.44% | |
Total Long-Term Assets | 2.8M -41.05% | 4.7M -19.25% | 5.8M -24.48% | 7.7M -5.44% | |
Total Assets | 289.0M -32.85% | 430.3M -22.00% | 551.7M +2.30% | 539.3M +18.66% | |
Income Taxes Payable | 194,000 N/A | 0 N/A | 0 -100.00% | 853,000 -47.41% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 36.6M -30.66% | 52.7M -23.99% | 69.4M +22.45% | 56.6M +28.91% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 500,000 -41.11% | 849,000 -52.30% | 1.8M -32.06% | 2.6M -94.51% | |
Total Liabilities | 72.8M -21.89% | 93.2M -18.50% | 114.3M +8.56% | 105.3M +16.95% | |
Retained Earnings | -1.2B +13.00% | -1.1B +18.66% | -888.6M +49.00% | -596.4M +65.86% | |
Total Stockholders Equity | 216.2M -35.88% | 337.2M -22.89% | 437.3M +0.80% | 433.8M +19.19% | |
Total Shares Outstanding | 69.1M -3.08% | 71.3M +0.73% | 70.8M +19.37% | 59.3M +30.31% | |
Cash Flow | |||||
Cash from Operating Activities | -125.2M -26.70% | -170.9M -17.79% | -207.8M +26.91% | -163.8M +6.27% | |
Capital Expenditures | 0 -100.00% | 221,000 -62.09% | 583,000 -77.12% | 2.5M -58.28% | |
Cash from Investing Activities | 131.6M -25.45% | 176.6M +497.14% | -44.5M -61.06% | -114.2M +530.31% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -4.3M -4,064.81% | 108,000 -99.95% | 237.3M -9.09% | 261.0M +46.23% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | -283.57% N/A | N/A N/A | N/A N/A | |
Return on Assets | -38.11% +12.83% | -33.77% -36.94% | -53.56% +12.40% | -47.66% +23.11% | |
Return on Equity | -49.53% +15.66% | -42.83% -36.16% | -67.09% +13.00% | -59.37% +25.77% | |
Revenue Growth | -100.00% N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 6.93 -5.42% | 7.32 +2.26% | 7.16 -10.25% | 7.98 -0.05% | |
Cash Ratio | 0.98 +53.13% | 0.64 +59.08% | 0.40 -46.84% | 0.76 -44.05% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow